Creative Medical Tech: Board & Executive Compensation Changes
Ticker: CELZ · Form: 8-K · Filed: Nov 12, 2025 · CIK: 1187953
| Field | Detail |
|---|---|
| Company | Creative Medical Technology Holdings, INC. (CELZ) |
| Form Type | 8-K |
| Filed Date | Nov 12, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $100,000, $25,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation
TL;DR
Board shakeup and pay changes at Creative Medical Tech.
AI Summary
Creative Medical Technology Holdings, Inc. announced on November 6, 2025, a change in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new board members, and adjustments to compensatory plans.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, and future financial performance.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- Creative Medical Technology Holdings, Inc. (company) — Registrant
- November 6, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 211 E Osborn Road, Phoenix, AZ 85012 (address) — Principal executive offices
FAQ
What specific roles have been affected by the departure of officers or directors?
The filing indicates changes related to 'Departure of Directors or Certain Officers' and 'Appointment of Certain Officers,' but does not specify the exact roles in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on November 6, 2025.
What is the state of incorporation for Creative Medical Technology Holdings, Inc.?
The company is incorporated in Nevada.
What is the principal executive office address for the company?
The principal executive offices are located at 211 E Osborn Road, Phoenix, AZ 85012.
What other items are covered in this 8-K filing besides director and officer changes?
The filing also covers 'Election of Directors,' 'Appointment of Certain Officers,' and 'Compensatory Arrangements of Certain Officers,' as well as 'Financial Statements and Exhibits'.
Filing Stats: 430 words · 2 min read · ~1 pages · Grade level 12.1 · Accepted 2025-11-12 06:12:58
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share CELZ The Nasdaq Stock Mar
- $100,000 — ef Financial Officer, in the amounts of $100,000 and $25,000, respectively. Item 9.01 F
- $25,000 — Officer, in the amounts of $100,000 and $25,000, respectively. Item 9.01 Financial Sta
Filing Documents
- celz_8k.htm (8-K) — 21KB
- 0001477932-25-008027.txt ( ) — 130KB
- celz-20251106.xsd (EX-101.SCH) — 5KB
- celz-20251106_lab.xml (EX-101.LAB) — 14KB
- celz-20251106_cal.xml (EX-101.CAL) — 1KB
- celz-20251106_pre.xml (EX-101.PRE) — 9KB
- celz-20251106_def.xml (EX-101.DEF) — 2KB
- celz_8k_htm.xml (XML) — 4KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Creative Medical Technology Holdings, Inc. Date: November 12, 2025 By: /s/ Timothy Warbington Timothy Warbington, Chief Executive Officer 3